Notably, heterozygotes for germline P/LP variants in GATA2, ETV6, and RUNX1 (both cohorts), and DDX41 (UKBB only) have significantly increased risk for developing hematological malignancies. The gene discussed is GATA2; the disease is hematologic disorder.